ADMA Biologics Inc
Last updated September 27, 2026
Organization details
- Legal name
- ADMA Biologics Inc
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ADMA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001368514
Board of directors
-
Adam S. Grossman · Director · President and CEOSince 2023
-
Alison Cecily Finger · DirectorSince 2023
-
Bryant Fong · DirectorSince 2023
-
Eduardo Rene Salas · DirectorSince 2024
-
Jerrold B. Grossman · DirectorSince 2023
-
Lawrence P. Guiheen · DirectorSince 2023
-
Martha J. Demski · DirectorSince 2023
-
Steve Elms · DirectorSince 2023
-
Young Kwon · DirectorSince 2023
Chief executives
Adam S. Grossman
· President and CEO
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via Martha J. Demski
- via Martha J. Demski
- via Steve Elms
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $468,294
- 5 purchases by 2 insiders
- Sold, last 12 months
- $1,901,430
- 11 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 24, 2026 | Kestenberg-Messina Kaitlin M. Officer (COO and SVP, Compliance) | Shares withheld for tax | −3,177 | $8.37 | $26,591 |
| Jul 16, 2026 | Kohler Terry Officer (CFO and Treasurer) | Grant or award | +85,130 | — | — |
| May 27, 2026 | Jerrold B. Grossman Director | Open-market purchase | +6,400 | $7.91 | $50,624 |
| May 12, 2026 | Jerrold B. Grossman Director | Open-market purchase | +12,500 | $8.01 | $100,125 |
| May 11, 2026 | Jerrold B. Grossman Director | Open-market purchase | +12,500 | $8.01 | $100,125 |
| Apr 1, 2026 | Kestenberg-Messina Kaitlin M. Officer (COO and SVP, Compliance) | Shares withheld for tax | −20,362 | $9.11 | $185,498 |
| Mar 17, 2026 | Lawrence P. Guiheen Director | Gift | −30,000 | — | — |
| Mar 17, 2026 | Lawrence P. Guiheen Director | Gift | +30,000 | — | — |
| Mar 16, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Option exercise | +15,000 | $5.40 | $81,000 |
| Mar 16, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Open-market sale | −15,000 | $15.16 | $227,400 |
| Mar 16, 2026 | Adam S. Grossman Director, Officer (President and CEO) | Open-market sale | −6,000 | $15.16 | $90,960 |
| Mar 13, 2026 | Lawrence P. Guiheen Director | Option exercise | +30,000 | $3.66 | $109,800 |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Officer (COO and SVP, Compliance) | Other | −91,266 | — | — |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Officer (COO and SVP, Compliance) | Option exercise | +2,500 | $5.00 | $12,500 |
| Mar 9, 2026 | Kestenberg-Messina Kaitlin M. Officer (COO and SVP, Compliance) | Option exercise | +1,250 | $4.31 | $5,388 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.